Aspicor 100

Страна: Армения

Язык: английский

Источник: Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

Активный ингредиент:

acetylsalicylic acid

Доступна с:

Coral Laboratories Ltd.

ИНН (Международная Имя):

acetylsalicylic acid

дозировка:

100mg

Фармацевтическая форма:

tablets gastro-resistant

Тип рецепта:

OTC

Характеристики продукта

                                PRODUCT : ASPICOR 100 (Gastro-resistant Acetylsalicylic acid Tablets
BP 100 mg)
COUNTRY : REPUBLIC OF ARMENIA
THE SUMMARY OF PRODUCT
CHARACTERISTICS
1.
NAME OF THE MEDICINAL PRODUCT :
TRADE NAME : ASPICOR 100
DOSE
: 100 mg
DOSAGE FORM : Gastro-resistant Tablet For Oral Use.
2.
COMPLETE QUALITATIVE AND QUANTITATIVE COMPOSITION OF THE PRODUCT
COMPOSITION :
Each gastro-resistant tablet contains :
acetylsalicylic acid 100 mg
Excipients
q.s.
Colour : Titanium Dioxide
SR.
NO.
APPROVED NAME
(INN)
LABEL
CLAIM
PER TABLET
(IN MG)
OVERAGES
QTY./TABLET
IN MG
COATING OF PURIFIED TALC
1
Stearic Acid
2.00
---
2.00
2
Purified Talc
8.00
---
8.00
3
Isopropyl Alcohol
0.4902
---
0.4902
4
Dichloromethane
0.9803
---
0.9803
LUBRICATION
5
Acetylsalicylic acid
(Directly Compressible
Granules)
100.00
---
100.00
6
Calcium Hydrogen Phosphate
23.00
---
23.00
7
Microcrystalline Cellulose
15.00
---
15.00
8
Croscarmellose Sodium
5.00
---
5.00
TOTAL
153.00
---
153.00
ENTERIC COATING
9
Cellulose Acetate Phthalate
15.30
---
15.30
10
Isopropyl Alcohol
75.00
---
75.00
11
Dichloromethane
200.00
---
200.00
12
Titanium Dioxide
1.50
---
1.50
PRODUCT : ASPICOR 100 (Gastro-resistant Acetylsalicylic acid Tablets
BP 100 mg)
COUNTRY : REPUBLIC OF ARMENIA
3.
PHARMACEUTICAL FORM
Tablets
4.
CLINICAL PARTICULARS
4.1
THERAPEUTIC INDICATIONS
Gastro-resistant acetylsalicylic acid Tablets BP indicated in the
following:
-Secondary prevention of myocardial infarction.
- Prevention of cardiovascular morbidity in patients suffering from
stable angina pectoris.
- History of unstable angina pectoris, except during the acute phase.
- Prevention of graft occlusion after Coronary Artery Bypass Grafting
(CABG).
- Coronary angioplasty, except during the acute phase.
- Secondary prevention of transient ischaemic attacks (TIA) and
ischaemic cerebrovascular
accidents (CVA), provided intracerebral haemorrhages have been ruled
out.
Gastro-resistant Acetylsalicylic acid Tablets BP is not recommended in
emergency
situations. It is restricted to secondary prevention with chronic
treat
                                
                                Прочитать полный документ
                                
                            

Документы на других языках

тонкая брошюра тонкая брошюра русский 14-02-2017

Поиск оповещений, связанных с этим продуктом

Просмотр истории документов